Livtencity (maribavir)
pCPA File Number:
22070
Negotiation Status:
Active Negotiation
Indication(s):
post-transplant cytomegalovirus (CMV) infection/disease
Sponsor/Manufacturer:
Takeda Canada Inc.
CADTH Project Number:
SR0720
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable